- Home
- TNGX vs ALTI Comparison
TNGX vs ALTI Comparison
Compare TNGX & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ALTI
- Stock Information
- Founded
- TNGX 2014
- ALTI 2020
- Country
- TNGX United States
- ALTI United States
- Employees
- TNGX N/A
- ALTI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ALTI Investment Managers
- Sector
- TNGX Health Care
- ALTI Finance
- Exchange
- TNGX Nasdaq
- ALTI Nasdaq
- Market Cap
- TNGX 317.4M
- ALTI 283.9M
- IPO Year
- TNGX N/A
- ALTI N/A
- Fundamental
- Price
- TNGX $1.95
- ALTI $2.75
- Analyst Decision
- TNGX Strong Buy
- ALTI
- Analyst Count
- TNGX 7
- ALTI 0
- Target Price
- TNGX $12.33
- ALTI N/A
- AVG Volume (30 Days)
- TNGX 817.7K
- ALTI 116.9K
- Earning Date
- TNGX 05-07-2025
- ALTI 05-09-2025
- Dividend Yield
- TNGX N/A
- ALTI N/A
- EPS Growth
- TNGX N/A
- ALTI N/A
- EPS
- TNGX N/A
- ALTI N/A
- Revenue
- TNGX $42,069,000.00
- ALTI $206,935,000.00
- Revenue This Year
- TNGX N/A
- ALTI N/A
- Revenue Next Year
- TNGX N/A
- ALTI $11.83
- P/E Ratio
- TNGX N/A
- ALTI N/A
- Revenue Growth
- TNGX 15.17
- ALTI N/A
- 52 Week Low
- TNGX $1.72
- ALTI $2.40
- 52 Week High
- TNGX $12.02
- ALTI $6.99
- Technical
- Relative Strength Index (RSI)
- TNGX 37.66
- ALTI 22.44
- Support Level
- TNGX $1.80
- ALTI $3.33
- Resistance Level
- TNGX $2.01
- ALTI $3.64
- Average True Range (ATR)
- TNGX 0.21
- ALTI 0.27
- MACD
- TNGX 0.01
- ALTI -0.05
- Stochastic Oscillator
- TNGX 31.94
- ALTI 20.97
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments that includes Wealth Management and Strategic Alternatives. Wealth Management includes providing holistic solutions for their wealth management clients through their comprehensive range of wealth management services, including investment management and advisory services. Strategic Alternatives segment, it assists their investors with alternative investments and co-investments by providing access to highly differentiated opportunities in these areas.